What We're Reading: Page 323
Industry reads hand-picked by our editors
Jun 07, 2016
-
Forbes
The world's most reputable pharmaceutical companies in 2016
-
The Clarion-Ledger
US seizes Mississippi properties in pharmaceutical scheme
-
The Motley Fool
These 2 catalysts helped push Galena Biopharma Inc. 31% higher in May
-
IPWatchdog
IP protection critical for biopharma given number, cost and complexity of clinical trials
Jun 06, 2016
Jun 03, 2016
-
EP Vantage
Strimvelis approval could rejuvenate gene therapy arena
-
Washington Post
Stanford researchers ‘stunned’ by stem cell experiment that helped stroke patient walk
-
Bloomberg
Valeant Gets Default Notice Due to Quarterly Filing Delay
-
Reuters
Botswana gets GSK's modern HIV drug in largest ever Africa tender
Jun 02, 2016
Jun 01, 2016
May 31, 2016
-
Reuters
Roche and Novartis face off in biosimilar drug battle
-
Chicago Tribune
Shareholders approve $32 billion Baxalta-Shire merger
-
New York Times
Emmanuelle Charpentier's Still-Busy Life After Crispr
-
Wall Street Journal
FDA Asks Teva for More Information on Huntington’s Drug
Previous
